Information of patients
ADVERSE EVENTS, ADVERSE EFFECTS, ADVERSE EVENT
As shown in Flow chart of patients included and excluded in this trial.· baseline characteristics of participants.After the treatment schedule is completed, participants were followed up on 4th, 8th, and 12th week. During follow-up, only a small number of patients showed mild adverse events (AEs) after the intervention, and no severe adverse event occurred (Adverse effects occurred in participants.